Ibandronat Sandoz i.v., Injektionslösung

7680605320012 CH-60532 Injektionslösung
Ibandronat Sandoz i.v., Injektionslösung
Ibandronat Sandoz i.v., Injektionslösung
Ibandronat Sandoz i.v., Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Spritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
14/12/2021
Summary of Product Characteristics
Français
14/12/2021
Summary of Product Characteristics
Italien
14/12/2021

Detailed composition

Substance Quantity Type Category
(N/A)
3.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
12.0 MG Substance HBESI

Reimbursement information

Public price
CHF 64.35
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2011

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
60532
Drug name
Ibandronat Sandoz i.v., Injektionslösung
Galenic form
LSPA
ATC Code
M05BA06
Authorization status
Z
Dispensing category
B
First authorization
29/07/2010
Authorization expiration date
31/12/9999
IT Number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Package details

Description (FR)
IBANDRONATE Sandoz sol inj 3 mg/3ml ser pré 3 ml
Description (DE)
IBANDRONAT Sandoz Inj Lös 3 mg/3ml Fertspr 3 ml
Market launch
29/07/2010
Narcotic (BTM)
No

Original drug

Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680574240014
CHF 210.75
View original